We are live on ! Find out more
SCM

Silvant Capital Management Portfolio holdings

AUM $2.89B
1-Year Est. Return 34.45%
This Fund
S&P 500
This Quarter Est. Return
+3.91%
1 Year Est. Return
+34.45%
3 Year Est. Return
+148.47%
5 Year Est. Return
+205.7%
10 Year Est. Return
AUM
$585M
AUM Growth
+$104K
Cap. Flow
-$14.4M
Cap. Flow %
-2.46%
Top 10 Hldgs %
42.57%
Holding
347
New
14
Increased
7
Reduced
65
Closed
13

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.51M
2
LLY icon
Eli Lilly
LLY
+$1.38M
3
TWLO icon
Twilio
TWLO
+$864K
4
TXG icon
10x Genomics
TXG
+$824K
5
BALY icon
Bally's
BALY
+$308K

Top Sells

Rank Stock Value
1
HD icon
Home Depot
HD
+$4.77M
2
RTX icon
RTX Corp
RTX
+$1.87M
3
AMAT icon
Applied Materials
AMAT
+$1.01M
4
MSFT icon
Microsoft
MSFT
+$1M
5
AKAM icon
Akamai
AKAM
+$947K

Sector Composition

Rank Sector Weight
1 Technology 31.27%
2 Healthcare 14.59%
3 Consumer Discretionary 14.33%
4 Financials 13.09%
5 Communication Services 12.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISRG icon
51
Intuitive Surgical
ISRG
$127B
$2.99M 0.51%
12,132
-348
-3% -$87.6K
AXP icon
52
American Express
AXP
$227B
$2.98M 0.51%
20,976
-557
-3% -$73.6K
RCL icon
53
Royal Caribbean
RCL
$85.1B
$2.84M 0.48%
33,166
-946
-3% -$75K
CME icon
54
CME Group
CME
$96.3B
$2.82M 0.48%
13,810
CI icon
55
Cigna
CI
$73.7B
$2.78M 0.47%
11,502
EQIX icon
56
Equinix
EQIX
$101B
$2.76M 0.47%
4,065
-111
-3% -$76.2K
MRK icon
57
Merck
MRK
$322B
$2.75M 0.47%
37,024
EXAS
58
DELISTED
Exact Sciences
EXAS
$2.75M 0.47%
20,831
-640
-3% -$87.6K
PLD icon
59
Prologis
PLD
$135B
$2.64M 0.45%
24,929
COO icon
60
Cooper Companies
COO
$14.1B
$2.63M 0.45%
27,332
INFO
61
DELISTED
IHS Markit Ltd. Common Shares
INFO
$2.59M 0.44%
26,795
-735
-3% -$67.2K
SPY icon
62
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$2.56M 0.44%
6,445
-1,216
-16% -$469K
CMG icon
63
Chipotle Mexican Grill
CMG
$47.2B
$2.42M 0.41%
85,050
-2,300
-3% -$66.5K
FIS icon
64
Fidelity National Information Services
FIS
$23.1B
$2.4M 0.41%
17,047
-1,308
-7% -$179K
VRTX icon
65
Vertex Pharmaceuticals
VRTX
$121B
$2.35M 0.4%
10,917
-345
-3% -$75.8K
NOC icon
66
Northrop Grumman
NOC
$77.1B
$2.3M 0.39%
7,096
TDOC icon
67
Teladoc Health
TDOC
$1.22B
$2.27M 0.39%
12,516
-343
-3% -$79.6K
ALGN icon
68
Align Technology
ALGN
$12.1B
$2.26M 0.39%
4,173
OLED icon
69
Universal Display
OLED
$3.68B
$2.24M 0.38%
9,468
-3,051
-24% -$705K
DPZ icon
70
Domino's
DPZ
$11.5B
$2.21M 0.38%
6,002
-1,198
-17% -$442K
TW icon
71
Tradeweb Markets
TW
$21.4B
$2.19M 0.37%
29,636
PAYC icon
72
Paycom
PAYC
$7.64B
$2.06M 0.35%
5,564
-155
-3% -$61.1K
PPG icon
73
PPG Industries
PPG
$24.6B
$2.03M 0.35%
13,516
GILD icon
74
Gilead Sciences
GILD
$162B
$1.97M 0.34%
30,478
PODD icon
75
Insulet
PODD
$11.5B
$1.95M 0.33%
7,469
-424
-5% -$114K

Similar funds

Silvant Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Silvant Capital Management held 347 positions worth $585M, up 0.02% from $585M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Silvant Capital Management's Q1 2021 filing shows 14 new, 7 increased, 65 reduced and 13 closed positions. Its largest new stake was 10x Genomics: 4,773 shares worth $864K. The largest sale was Home Depot, an estimated $4.77M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Silvant Capital Management's largest Q1 2021 buy was 10x Genomics: 4,773 shares worth $864K.
  • Silvant Capital Management added most to NVIDIA in Q1 2021, an estimated $1.51M increase.
  • Silvant Capital Management's biggest Q1 2021 reduction was Home Depot, cutting an estimated $4.77M.
  • Silvant Capital Management fully exited Akamai in Q1 2021, selling an estimated $947K.
  • Silvant Capital Management's ten largest holdings make up 43% of its $585M portfolio in Q1 2021.
  • Silvant Capital Management opened 14 new positions and closed 13 in Q1 2021.
  • Silvant Capital Management's portfolio value rose 0.02% quarter-over-quarter to $585M.

Based on Silvant Capital Management's 13F filing for Q1 2021, filed 11 May 2021.